Societal CDMO Inc - Company Profile
Powered by 
All the data and insights you need on Societal CDMO Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Societal CDMO Inc Strategy Report
- Understand Societal CDMO Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Societal CDMO Inc (Societal CDMO), formerly Recro Pharma Inc, provides contract development and manufacturing organization (CDMO) services. The company harnesses formulation capabilities and proprietary delivery technologies for the development, manufacture, and commercialization of pharmaceutical products of its partners. It manufactures products such as Ritalin LA, Verelan SR, Focalin XR, Verelan PM, Verapamil PM, Verapamil SR, Donnatal liquids and tablets with commercial partners. The company’s commercial partners include as Teva, Novartis, Lannett, Advanz and Infectopharma. It also provides services such as clinical trials, analytical services, facilities and equipment, contract development and manufacturing services, commercial packaging and logistics. The company has a manufacturing facility in Gainesville, Georgia, the US. Societal CDMO is headquartered in Exton, Pennsylvania, the US.
Headquarters
United States of America
Address
1 E. Uwchlan Ave, Suite 112, Exton, Pennsylvania, 19341
Website
www.societalcdmo.com
Telephone
1 770 5348239
No of Employees
258
Industry
Pharmaceuticals and Healthcare
Revenue (2023)
$94.6M
Societal CDMO Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Ritalin LA | Contract Development and Manufacturing Services | Ritalin LA |
| Focalin XR | Commercial Manufacturing | Focalin XR |
| Verelan PM | Commercial Packaging & Logistics | Verelan PM |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In September, the company entered into an agreement with several existing customers to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development. |
| 2023 | Contracts/Agreements | In July, the company was selected by Spinnaker Biosciences to provide CDMO services in support of the company’s clinical development of a novel therapeutic candidate. |
| 2023 | Contracts/Agreements | In June, the company entered into an agreement with CivicaScript to produce clinical trial materials intended for registration with the U.S. Food and Drug Administration. |
Competitor Comparison
| Key Parameters | Societal CDMO Inc | Catalent Inc | Recipharm AB | Quotient Sciences Ltd | Adare Pharma Solutions |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Sweden | United Kingdom | United States of America |
| City | Exton | Somerset | Stockholm | Nottingham | Lawrenceville |
| State/Province | Pennsylvania | New Jersey | Stockholm | England | New Jersey |
| No. of Employees | 258 | 17,800 | 8,747 | 555 | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Wayne B. Weisman | Chairman | Executive Board | 2008 | 66 |
| J. David Enloe, Jr. | Chief Executive Officer; President; Director | Executive Board | 2020 | 59 |
| Ryan D. Lake | Senior Vice President; Chief Financial Officer | Senior Management | 2018 | 45 |
| Scott Rizzo | Senior Vice President; Chief Operating Officer | Senior Management | 2015 | - |
| Erica Raether | Chief People Officer; Senior Vice President | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer